118 related articles for article (PubMed ID: 34821169)
1. Periductal Stromal Tumor of the Breast: One Institution's Review of 6 Tumors Over a 22 Year Period With Immunohistochemical Analysis.
Zhao L; Komforti MK; Dawson A; Rowe JJ
Int J Surg Pathol; 2022 Jun; 30(4):370-377. PubMed ID: 34821169
[No Abstract] [Full Text] [Related]
2. Periductal stromal tumor: a rare lesion with low-grade sarcomatous behavior.
Burga AM; Tavassoli FA
Am J Surg Pathol; 2003 Mar; 27(3):343-8. PubMed ID: 12604890
[TBL] [Abstract][Full Text] [Related]
3. Periductal Stromal Tumor of the Breast: Case Report and Literature Review.
Fard EV; Zhang S
Ann Clin Lab Sci; 2018 Nov; 48(6):770-775. PubMed ID: 30610048
[TBL] [Abstract][Full Text] [Related]
4. [Clinicopathologic features and prognostic factors of malignant phyllodes tumors].
Jia C; Mei F; Zheng J; You JF; Liu JY
Zhonghua Bing Li Xue Za Zhi; 2013 Nov; 42(11):729-34. PubMed ID: 24447548
[TBL] [Abstract][Full Text] [Related]
5. Periductal Stromal Tumors and Phyllodes Tumors Represent a Spectrum of Fibroepithelial Lesions: What Is in a Name?
Wabik A; Van Bockstal MR; Berlière M; Galant C
Int J Surg Pathol; 2021 Feb; 29(1):97-101. PubMed ID: 32517525
[TBL] [Abstract][Full Text] [Related]
6. CD10, actin, and vimentin expression in breast phyllodes tumors correlates with tumor grades of the WHO grading system.
Tsai WC; Jin JS; Yu JC; Sheu LF
Int J Surg Pathol; 2006 Apr; 14(2):127-31. PubMed ID: 16703173
[TBL] [Abstract][Full Text] [Related]
7. Periductal Stromal Sarcoma of the Breast With Liposarcomatous Differentiation: A Case Report With 10-Year Follow-up and Literature Review.
White SR; Auguste LJ; Guo H; Bhuiya T
Int J Surg Pathol; 2015 May; 23(3):221-4. PubMed ID: 25614463
[TBL] [Abstract][Full Text] [Related]
8. Mammary NOS-type sarcoma with CD10 expression: a rare entity with features of myoepithelial differentiation.
Leibl S; Moinfar F
Am J Surg Pathol; 2006 Apr; 30(4):450-6. PubMed ID: 16625090
[TBL] [Abstract][Full Text] [Related]
9. An approach to malignant mammary phyllodes tumors detection.
Ilić I; Randelović P; Ilić R; Katić V; Milentijević M; Velicković L; Krstić M
Vojnosanit Pregl; 2009 Apr; 66(4):277-82. PubMed ID: 19441158
[TBL] [Abstract][Full Text] [Related]
10. Phyllodes tumours of the breast: the role of CD34, vascular endothelial growth factor and β-catenin in histological grading and clinical outcome.
Ho SK; Thike AA; Cheok PY; Tse GM; Tan PH
Histopathology; 2013 Sep; 63(3):393-406. PubMed ID: 23772632
[TBL] [Abstract][Full Text] [Related]
11. Comparison of stromal CD10 expression in benign, borderline, and malignant phyllodes tumors among Egyptian female patients.
Ibrahim WS
Indian J Pathol Microbiol; 2011; 54(4):741-4. PubMed ID: 22234101
[TBL] [Abstract][Full Text] [Related]
12. Expression of cancer stem cell markers in breast phyllodes tumor.
Kim SI; Koo JS
Cancer Biomark; 2020; 29(2):235-243. PubMed ID: 32675396
[TBL] [Abstract][Full Text] [Related]
13. Recent developments in the histological diagnosis of spindle cell carcinoma, fibromatosis and phyllodes tumour of the breast.
Lee AH
Histopathology; 2008 Jan; 52(1):45-57. PubMed ID: 18171416
[TBL] [Abstract][Full Text] [Related]
14. Critical appraisal of stromal CD10 staining in fibroepithelial lesions of breast with a special emphasis on expression patterns and correlation with WHO grading.
Puri V; Jain M; Mahajan G; Pujani M
J Cancer Res Ther; 2016; 12(2):667-70. PubMed ID: 27461629
[TBL] [Abstract][Full Text] [Related]
15. A subset of malignant phyllodes tumors express p63 and p40: a diagnostic pitfall in breast core needle biopsies.
Cimino-Mathews A; Sharma R; Illei PB; Vang R; Argani P
Am J Surg Pathol; 2014 Dec; 38(12):1689-96. PubMed ID: 25046342
[TBL] [Abstract][Full Text] [Related]
16. Expression of vascular endothelial growth factor, CD10, and factor 8 in phyllodes tumor: A 5-year study of 38 cases.
Chaudhary D; Singh M; Kushwaha P; Agarwal R; Singh V; Mandal S; Khurana N; Mishra A
J Cancer Res Ther; 2020; 16(6):1408-1411. PubMed ID: 33342805
[TBL] [Abstract][Full Text] [Related]
17. In phyllodes tumour of the breast expression of c-kit but not of ALDH1A1 is associated with adverse clinico-pathological features.
Chougule A; Bal A; Das A; Kohli PS; Singh G
Virchows Arch; 2016 Dec; 469(6):651-658. PubMed ID: 27696244
[TBL] [Abstract][Full Text] [Related]
18. Phyllodes tumors of the breast: clinicopathological analysis of 106 cases from a single institution.
Efared B; Ebang GA; Tahiri L; Sidibé IS; Erregad F; Hammas N; Melhouf MA; Banani A; Chbani L; Fatemi HE
Breast Dis; 2018; 37(3):139-145. PubMed ID: 29332027
[TBL] [Abstract][Full Text] [Related]
19. An immunohistochemical study of metaplastic spindle cell carcinoma, phyllodes tumor and fibromatosis of the breast.
Dunne B; Lee AH; Pinder SE; Bell JA; Ellis IO
Hum Pathol; 2003 Oct; 34(10):1009-15. PubMed ID: 14608534
[TBL] [Abstract][Full Text] [Related]
20. GATA3 expression in breast carcinoma: utility in triple-negative, sarcomatoid, and metastatic carcinomas.
Cimino-Mathews A; Subhawong AP; Illei PB; Sharma R; Halushka MK; Vang R; Fetting JH; Park BH; Argani P
Hum Pathol; 2013 Jul; 44(7):1341-9. PubMed ID: 23375642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
